Repligen | RGEN - Market Capitalization


Repligen reported $8.38B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agilent USD 41.49B 8.93B Sep/2025
Align Technology USD 9.08B 4.65B Sep/2025
Bio Techne USD 8.66B 595M Sep/2025
BioMarin Pharmaceutical USD 10.4B 142M Sep/2025
Bristol-Myers Squibb USD 91.8B 2.4B Sep/2025
Bruker USD 4.93B 1.31B Sep/2025
Charles River Laboratories USD 7.31B 57M Sep/2025
Danaher USD 161.7B 29.34B Dec/2025
Dentsply International USD 2.53B 633M Sep/2025
Exact Sciences USD 10.36B 334M Sep/2025
General Electric Aerospace USD 324.91B 5.91B Dec/2025
Henry Schein USD 8.01B 1.15B Sep/2025
Illumina USD 14.09B 1.01B Sep/2025
IQVIA Holdings USD 32.29B 5.03B Sep/2025
Mettler Toledo International USD 25.29B 878M Sep/2025
Myriad Genetics USD 494M 316M Jun/2025
Pfizer USD 147.57B 12.48B Feb/2026
Repligen USD 7.52B 532M Sep/2025
Revvity USD 13.23B 3.47B Feb/2026
Standard Biotools USD 521M 24M Feb/2026
Thermo Fisher Scientific USD 217.7B 42.4B Dec/2025
Waters USD 17.36B 3.61B Sep/2025
West Pharmaceutical Services USD 18.86B 3.14B Sep/2025